Neoadjuvant sintilimab combined with chemotherapy in resectable locally advanced non-small cell lung cancer: case series and literature review

Table 3 Outcomes of neoadjuvant treatment

Patients no	Interval time between the last neoadjuvant treatment and operation, days	The best radical response	Pathological response (pCR or no pCR)
1	28	SD	no pCR
2	30	SD	pCR
3	35	PR	pCR
4	48	PR	pCR
5	38	SD	pCR
6	37	SD	pCR
7	33	PR	pCR
8	29	SD	pCR
9	69	PR	no pCR
10	37	SD	no pCR
11	77	SD	pCR
12	37	PR	no pCR
13	46	PR	pCR

PR partial response, SD stable disease, CR complete response, pCR pathological complete response

ISSN: 1477-7819